BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 157 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,844,213 | +153.1% | 542,968 | +151.7% | 0.01% | +150.0% |
| Q2 2023 | $1,518,824 | -46.5% | 215,742 | -36.6% | 0.00% | -50.0% |
| Q1 2023 | $2,838,861 | +57.9% | 340,391 | +117.4% | 0.00% | +33.3% |
| Q4 2022 | $1,797,458 | -99.9% | 156,573 | -34.7% | 0.00% | -40.0% |
| Q3 2022 | $3,022,488,000 | +602.2% | 239,880 | +489.6% | 0.01% | +400.0% |
| Q2 2022 | $430,416,000 | +2.4% | 40,682 | +57.4% | 0.00% | 0.0% |
| Q1 2022 | $420,240,000 | -53.9% | 25,845 | -60.8% | 0.00% | 0.0% |
| Q4 2021 | $912,106,000 | +44.6% | 65,856 | +50.0% | 0.00% | 0.0% |
| Q3 2021 | $630,900,000 | +138.2% | 43,904 | +162.1% | 0.00% | – |
| Q2 2021 | $264,865,000 | -14.7% | 16,753 | -45.2% | 0.00% | – |
| Q1 2021 | $310,673,000 | +122.2% | 30,548 | +62.8% | 0.00% | – |
| Q4 2020 | $139,814,000 | -1.2% | 18,767 | -54.5% | 0.00% | – |
| Q3 2020 | $141,536,000 | -16.9% | 41,204 | +15.3% | 0.00% | – |
| Q2 2020 | $170,287,000 | +20.7% | 35,737 | -49.3% | 0.00% | – |
| Q1 2020 | $141,034,000 | +138.0% | 70,517 | +310.5% | 0.00% | – |
| Q4 2019 | $59,268,000 | +18.5% | 17,179 | -1.6% | 0.00% | – |
| Q3 2019 | $50,017,000 | +7.6% | 17,458 | +42.4% | 0.00% | – |
| Q2 2019 | $46,469,000 | -74.9% | 12,261 | -46.0% | 0.00% | – |
| Q1 2019 | $184,868,000 | +61728.8% | 22,711 | +61281.1% | 0.00% | – |
| Q4 2018 | $299,000 | -98.8% | 37 | -98.9% | 0.00% | – |
| Q3 2018 | $24,851,000 | +33.2% | 3,257 | 0.0% | 0.00% | – |
| Q2 2018 | $18,663,000 | -80.7% | 3,257 | -84.0% | 0.00% | – |
| Q1 2018 | $96,893,000 | -3.5% | 20,313 | -0.7% | 0.00% | – |
| Q4 2017 | $100,439,000 | +131.8% | 20,456 | +147.4% | 0.00% | – |
| Q3 2017 | $43,335,000 | -12.0% | 8,270 | -6.6% | 0.00% | – |
| Q2 2017 | $49,228,000 | +1492.6% | 8,854 | +2306.0% | 0.00% | – |
| Q1 2017 | $3,091,000 | -88.1% | 368 | -91.1% | 0.00% | – |
| Q4 2016 | $26,029,000 | +15.6% | 4,112 | -19.5% | 0.00% | – |
| Q3 2016 | $22,517,000 | +172.3% | 5,106 | +75.3% | 0.00% | – |
| Q2 2016 | $8,270,000 | -94.6% | 2,912 | -80.3% | 0.00% | – |
| Q4 2015 | $152,694,000 | -10.7% | 14,796 | -1.3% | 0.00% | – |
| Q3 2015 | $170,932,000 | +89.8% | 14,994 | +148.5% | 0.00% | – |
| Q2 2015 | $90,073,000 | +504.5% | 6,033 | +265.6% | 0.00% | – |
| Q1 2015 | $14,900,000 | -63.6% | 1,650 | -60.6% | 0.00% | – |
| Q3 2014 | $40,988,000 | – | 4,191 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |